Results 91 to 100 of about 12,798 (141)

DESIGN AND EVALUATION OF CONTROLLED-RELEASE OCULAR INSERTS OF BRIMONIDINE-TARTRATE AND TIMOLOL MALEATE [PDF]

, 2017
Objective: The current work was attempted to formulate and evaluate a controlled-release matrix-type ocular inserts containing a combination of brimonidine tartrate and timolol maleate, with a view to sustain the drug release in the cul-de-sac of the eye.
B., Preethi G., Kunal, Prashanth
core   +1 more source

Consistent Intraocular Pressure Reduction by Solid Drug Nanoparticles in Fixed Combinations for Glaucoma Therapy

Advanced Science
Efficient topical drug delivery remains a significant challenge in glaucoma management. Although nanoparticle formulations offer considerable promise, their complex preparation processes, co‐delivery issues, and batch consistency have hindered their ...
Da Huang, Pedro Norat, Lin Qi, Anna Chernatynskaya, James D. Cole, Vimalin Jeyalatha Mani, Lei Xu, Xiaorong Liu, Hu Yang   +8 more
doaj   +1 more source

Aerobic L-tartrate Utilization by Bacillus Isolates

, 2019
Microbial utilization of uncommon C4 dicarboxylate L-tartrate is largely anaerobic, with aerobic L-tartrate utilization known for few bacterial species including Rhodopseudomonas sphaeroides and Pseudomonas putida.
Disha Patel, Aditi Buch
core   +1 more source

Comparative analysis of PLGA ocuserts of brimonidine tartrate prepared with different methods

European Pharmaceutical Journal
The eye is a highly sensitive organ with multiple physiological barriers that limit drug bioavailability and reduce patient compliance. Research studies are still going on to discover a novel drug delivery system for ocular delivery. The current research
Paramjot, Wadhwa Sheetu, Singh Saurabh, Baghel Dileep Singh, Kumar Bimlesh   +4 more
doaj   +1 more source

Vitreous concentration of topically applied brimonidine tartrate 0.2%

, 2001
Objective: To determine the vitreous concentration of brimonidine after topical administration of ...
Tyson, F., Alexander R Kent, David Small, David, R., Farrell Tyson, Fellows, D., Nussdorf, J. D., Jonathan D Nussdorf, Kent, A. R., Small, D., Robert David, Dan Fellows   +11 more
core   +1 more source

Intraocular pressure reduction using a fixed combination of timolol maleate 0.5% and brimonidine tartrate 0.2% administered three times daily

Clinical Ophthalmology, 2013
Elad Moisseiev, Shimon Kurtz, Moshe Lazar, Gabi ShemeshDepartment of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, IsraelBackground: The purpose of this study was to evaluate the safety and efficacy of a fixed combination of timolol maleate ...
Moisseiev E, Kurtz S, Lazar M, Shemesh G
doaj  

Brimonidine tartrate-induced delayed hypersensitivity reaction

TNOA Journal of Ophthalmic Science and Research, 2020
Chitaranjan Mishra, Vijayalakshmi A Senthilkumar   +1 more
doaj   +1 more source

Use of brimonidine tartrate to resolve telangiectatic matting: case report. [PDF]

J Vasc Bras, 2020
de Mello BAS, Beiriz YR, Bonatto AC, Maciel GSB, de Almeida LR, Corassa JM.   +5 more
europepmc   +1 more source

Yuvezzi™ (carbachol and brimonidine tartrate) dual-agent eyedrops: a new option for presbyopia. [PDF]

Ann Med Surg (Lond)
Abid MA, Abid MH, Afzal MD.
europepmc   +1 more source

The Efficacy of Brimonidine in Preventing Intraocular Pressure Elevation in the Provocative Test for Primary Angle-Closure Glaucoma

, 2008
The purpose of this study was to evaluate the efficacy of 0. 2% brimonidine tartrate in preventing intraocular pressure( IOP) elevation in the dark-prone provocative test for primary angle-closure glaucoma (PACG) .
洪伯廷;蕭朱杏, HUNG, POR-TYING;HSIAO, CHUHSING K.   +1 more
core